Vladonix
Vladonix is a complex peptide bioregulator preparation derived from thymus gland tissue, developed at the St. Petersburg Institute of Bioregulation and Gerontology. Research focuses on reversing thymic involution, supporting T-cell maturation, and restoring immune competence in aging individuals.
Overview
The thymus gland is the primary organ responsible for T-lymphocyte maturation and education. Beginning around puberty, the thymus undergoes progressive involution — a process in which functional thymic epithelium is gradually replaced by adipose tissue, resulting in dramatically reduced naive T-cell output by middle age. This thymic involution is considered a central driver of immunosenescence, the age-related decline in immune competence that increases susceptibility to infection, cancer, and autoimmune disease.
Vladonix represents the cytomedine approach to thymic regeneration — delivering a complex of tissue-specific regulatory peptides extracted from thymus tissue to support the restoration of thymic function. Khavinson's research group has studied thymic peptide bioregulators since the 1970s, producing an extensive body of work on their immunomodulatory and geroprotective effects (Khavinson, 2002). Vladonix complements the synthetic peptides in this lineage, including Vilon (KE dipeptide) and Thymalin (the injectable cytomedine predecessor), by providing a broader spectrum of thymus-derived regulatory signals in oral capsule form.
Mechanism of Action
Thymic Epithelial Cell Support
The peptide fractions in Vladonix are proposed to act on thymic epithelial cells (TECs), the stromal cells that create the microenvironment required for T-cell development. TECs produce cytokines, chemokines, and self-antigen complexes essential for positive and negative selection of thymocytes. Age-related loss of TEC function is a primary driver of thymic involution. Khavinson bioregulators have been shown to penetrate cell nuclei and interact with DNA at promoter regions, potentially reactivating gene expression programs silenced during aging (Khavinson et al., 2012).
T-Cell Maturation and Differentiation
By supporting thymic microenvironment function, Vladonix may promote the maturation of naive T-cells from bone marrow-derived progenitors. This includes both CD4+ helper T-cells and CD8+ cytotoxic T-cells. Restoration of naive T-cell output is critical for maintaining immune diversity — the ability to recognize and respond to novel pathogens and tumor neoantigens. Research on the related synthetic peptide Vilon has demonstrated normalization of CD4/CD8 ratios and enhanced T-cell proliferative responses in aging models (Khavinson et al., 2000).
Immune Homeostasis
Beyond T-cell production, thymic peptide bioregulators appear to modulate the balance between immune activation and tolerance. Dysregulation of this balance during aging contributes to both immunodeficiency and chronic low-grade inflammation (inflammaging). The complex peptide mixture in Vladonix may provide more comprehensive regulation of thymic homeostasis compared to single-peptide approaches, as it contains multiple regulatory signals acting on different aspects of thymic function.
Reconstitution Calculator
Research
Immunosenescence
The age-related decline in adaptive immunity encompasses reduced naive T-cell diversity, accumulation of senescent memory T-cells, impaired vaccine responses, and increased autoimmune reactivity. Thymic peptide bioregulators address this at its source — the thymus — rather than attempting to modulate peripheral immune responses. Research suggests that even partial restoration of thymic output can meaningfully improve immune parameters in elderly individuals, as the naive T-cell compartment is severely contracted in advanced age.
Combination Protocols
Vladonix is frequently studied alongside Bonomarlot (bone marrow bioregulator) in anti-aging protocols. The rationale is that effective immune reconstitution requires both a supply of progenitor cells from bone marrow and a functional thymic microenvironment for their maturation. This combination targets the two primary bottlenecks in age-related immune decline. Additional combinations with Endoluten (pineal bioregulator) address the neuroendocrine regulation of immune function through melatonin pathways.
Thymic Involution and Aging
Khavinson's research program has produced substantial evidence that thymic peptide preparations can partially reverse age-related thymic involution. In animal studies, administration of thymic peptide bioregulators has been associated with histological evidence of thymic regeneration, increased thymic cellularity, and enhanced output of naive T-cells. A landmark 15-year clinical observation study involving thymalin (the injectable predecessor to Vladonix) demonstrated reduced mortality and improved immune parameters in elderly participants (Khavinson & Morozov, 2003).
Thymus peptide bioregulators
Vladonix is a thymus-derived peptide preparation in the Khavinson 'cytomax' bioregulator family, developed at the St. Petersburg Institute of Bioregulation and Gerontology. These are low-molecular-weight peptide complexes isolated from calf thymus and proposed to act tissue-specifically to support T-lymphocyte maturation and normalize immune reactivity. Vladonix as a named product has not itself been evaluated in indexed clinical trials; the scientific rationale rests on decades of Russian research on the pharmaceutical thymus peptide thymalin.
- Thymus-specific peptide complex intended to support T-cell maturation
- Part of the Khavinson cytomax/cytogen bioregulator system
- No PubMed-indexed clinical trials of the Vladonix product specifically
Thymalin clinical and geroprotective evidence
The strongest human data in this lineage come from thymalin, a registered Russian thymus peptide drug. A long-term controlled study by Khavinson and Morozov reported that thymic and pineal peptide bioregulators normalized multiple physiologic indices and reduced mortality in elderly subjects over 6-8 years. These findings, while influential in the bioregulator field, come from non-randomized Russian studies with methodological limitations and have not been independently replicated in Western randomized trials.
- Thymalin associated with ~2-fold mortality reduction over 6-8 years in an elderly cohort
- Reported improvements in immune, cardiovascular and endocrine indices
- Evidence base is largely Russian, non-randomized and not independently replicated
Proposed epigenetic mechanism
Khavinson's group hypothesizes that short thymus peptides act as gene-regulatory signals, entering cells and binding regulatory DNA/promoter regions to modulate tissue-specific gene expression and protein synthesis. This 'peptide bioregulation' model is used to explain organ-specific rejuvenation effects, but the molecular mechanism remains unproven and controversial outside the originating laboratories.
- Proposed direct peptide-DNA interaction modulating gene expression
- Claimed tissue-specificity matching the source organ
- Mechanism not validated by independent molecular studies
Safety Profile
Vladonix has been used in Russia as part of bioregulator protocols without significant adverse effects reported in available literature. As a preparation of naturally occurring short peptides from thymus tissue, it is expected to be rapidly metabolized. However, formal Western-standard clinical trials with rigorous safety endpoints have not been published. Individuals with autoimmune conditions should exercise caution, as thymic stimulation could theoretically exacerbate autoimmune reactivity by increasing T-cell output. Patients with thymoma or other thymic neoplasms should avoid thymic stimulatory preparations. No drug interactions have been formally characterized.
Pharmacokinetic Profile
- Half-life
- Not established
Quick Start
- Route
- Oral (capsules)
Molecular Structure
- Formula
- Not applicable (multi-component preparation)
- CAS
- Not available
Research Indications
Research / Bioregulator Uses
Marketed as a thymus 'cytomax' peptide bioregulator to support maturation of T-lymphocytes and restore age-impaired immune function; based on Khavinson thymus-peptide research, not on trials of Vladonix itself.
Positioned within the Khavinson bioregulator framework for age-related decline; supporting human data come from the related peptide thymalin.
Research Protocols
oral
Vladonix complements the synthetic peptides in this lineage, including Vilon (KE dipeptide) and Thymalin (the injectable cytomedine predecessor), by providing a broader spectrum of thymus-derived regulatory signals in oral capsule form.
Interactions
Peptide Interactions
Vladonix is frequently studied alongside Bonomarlot (bone marrow bioregulator) in anti-aging protocols.
Quality Indicators
What to look for
- Human clinical trials conducted
- Naturally occurring compound
Frequently Asked Questions
References (7)
- [1][Khavinson VK (2002). Peptides and Ageing. Neuro Endocrinol Lett (2002)
- [3][Khavinson VK et al. (2000). Effects of Livagen (Lys-Glu-Asp-Ala) on chromatin activation in old rat hepatocytes. Bull Exp Biol Med (2000)
- [2][Khavinson VK & Morozov VG (2003). Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett (2003)
- [4][Khavinson VK et al. (2012). Peptides tissue-specifically stimulate cell differentiation during their aging. Bull Exp Biol Med (2012)
- [6][Linkova NS et al. (2020). Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro. Bull Exp Biol Med (2020)
- [5][Khavinson VK et al. (2021). Peptide Regulation of Gene Expression: A Systematic Review. Molecules (2021)
- [7]Khavinson VKh Peptides and Ageing Neuro Endocrinol Lett (2002)
→ Review of organ-specific short-peptide bioregulators (including thymic/immune peptides) given in ~10-day repeated courses.
VITAMIN K
Vitamin K is a fat-soluble vitamin essential for blood coagulation and bone metabolism, existing primarily as K1 (phylloquinone) from plants and K2 (menaquinone
Vosoritide
Vosoritide (Voxzogo) is a 39-amino-acid analog of C-type natriuretic peptide (CNP) engineered for resistance to neutral endopeptidase, extending its half-life f